355
PURPOSE : To determine whether Myocet ( liposome - encapsulated doxorubicin ; The Liposome Company , Elan Corporation , Princeton , NJ ) in combination with cyclophosphamide significantly reduces doxorubicin cardiotoxicity while providing comparable antitumor efficacy in first - line treatment of metastatic breast cancer ( MBC ) .
 Chemical: Myocet; Chemical: doxorubicin; Chemical: cyclophosphamide; Chemical: doxorubicin; Disease: cardiotoxicity; Disease: breast cancer; Disease: MBC
Please list all entity words in the text that fit the category.Output format is "type1: word1; type2: word2". 
Option: Disease, Chemical 
Text: {0} 
Answer:
 Chemical: Myocet; Chemical: doxorubicin; Chemical: cyclophosphamide; Chemical: doxorubicin; Disease: cardiotoxicity; Disease: breast cancer; Disease: MBC